NervGen Pharma Corp. (NGEN.V)
6.02
+0.17
(+2.91%)
CAD |
TSXV |
Feb 20, 16:00
NervGen Pharma Total Liabilities (Quarterly) : 16.02M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Arch Biopartners, Inc. | 3.986M |
| Biocure Technology, Inc. | 0.4131M |
| Resverlogix Corp. | 134.60M |
| Microbix Biosystems, Inc. | 9.983M |
| Theratechnologies, Inc. | 108.88M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 13.08M |
| Shareholders Equity (Quarterly) | -2.942M |
| Debt to Equity Ratio | -0.0113 |
| Current Ratio | 0.7899 |
| Net Debt Paydown Yield | 0.01% |